Cargando…
Mortality Predictors in the Surgical Treatment of Active Infective Endocarditis
INTRODUCTION: Active infective endocarditis is associated with high morbidity and mortality. Surgery is indicated in high-risk conditions, and the main determinants of mortality in surgical treatment should be evaluated. OBJECTIVE: To identify mortality predictors in the surgical treatment of active...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Sociedade Brasileira de Cirurgia Cardiovascular
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5873776/ https://www.ncbi.nlm.nih.gov/pubmed/29617499 http://dx.doi.org/10.21470/1678-9741-2017-0132 |
_version_ | 1783310055762821120 |
---|---|
author | de Oliveira, Jenny Lourdes Rivas dos Santos, Magaly Arrais Arnoni, Renato Tambellini Ramos, Auristela Togna, Dorival Della Ghorayeb, Samira Kaissar Kroll, Roberto Tadeu Magro de Souza, Luiz Carlos Bento |
author_facet | de Oliveira, Jenny Lourdes Rivas dos Santos, Magaly Arrais Arnoni, Renato Tambellini Ramos, Auristela Togna, Dorival Della Ghorayeb, Samira Kaissar Kroll, Roberto Tadeu Magro de Souza, Luiz Carlos Bento |
author_sort | de Oliveira, Jenny Lourdes Rivas |
collection | PubMed |
description | INTRODUCTION: Active infective endocarditis is associated with high morbidity and mortality. Surgery is indicated in high-risk conditions, and the main determinants of mortality in surgical treatment should be evaluated. OBJECTIVE: To identify mortality predictors in the surgical treatment of active infective endocarditis in a long-term follow-up. METHODS: This prospective observational study involved 88 consecutive patients diagnosed with active infective endocarditis, who underwent surgery between January 2005 and December 2015. Fifty-eight (65.9%) patients were male, the mean age was 50.87±16.15 years. A total of 31 (35.2%) patients had a history of rheumatic fever; 48 (54.5%) had had heart surgery with prosthetic valve implantation; 45 (93.8%) had biological prosthetic valve endocarditis and 3 (6.3%) mechanical prosthetic valve; 40 (45.5%) patients had the disease in their native valve. The mean EuroSCORE II was 8.9±6.5%, and the main surgical indication was refractory heart failure in 38 (43.2%) patients. A total of 68 bioprosthesis (36 aortic, 32 mitral) and 29 mechanical prostheses (12 aortic, 17 mitral) were implanted and three mitral valve plasties performed. A total of 25 (28.4%) patients underwent double or triple valve procedures. Aortic annulus reconstruction by abscess was performed in 18 (20.5%) and six (6.81%) patients had combined procedure. The mean surgery time was 359±97.6 minutes. RESULTS: The overall survival in up to a 10-year follow-up period was 79.5%. In the univariate analysis, the main mortality predictors were positive blood cultures (P=0.003), presence of typical microorganisms (P=0.008), most frequently Streptococcus viridans (12 cases; 25%); C-reactive protein (hazard ratio [HR] 1.034, 95% confidence interval [CI] 1.000 to 1.070, P=0.04); creatinine clearance (HR 0.977, 95% CI 0.962 to 0.993, P=0.005); length of surgery: every five minutes multiplies the chance of death 1.005-fold (HR 1.005, 95% CI 1.001 to 1.009, P=0.0307); age (HR 1.060, 95% CI 1.026 to 1.096, P=0.001); and EuroSCORE II (HR 1.089, 95% CI 1.030 to 1.151, P=0.003). CONCLUSION: A positive blood culture with typical microorganism, C-reactive protein, age, EuroSCORE II, total surgical time and the presence of postoperative complications were the major predictors of mortality and significantly impacted survival in up to a 10-year follow-up period. |
format | Online Article Text |
id | pubmed-5873776 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | Sociedade Brasileira de Cirurgia Cardiovascular |
record_format | MEDLINE/PubMed |
spelling | pubmed-58737762018-04-02 Mortality Predictors in the Surgical Treatment of Active Infective Endocarditis de Oliveira, Jenny Lourdes Rivas dos Santos, Magaly Arrais Arnoni, Renato Tambellini Ramos, Auristela Togna, Dorival Della Ghorayeb, Samira Kaissar Kroll, Roberto Tadeu Magro de Souza, Luiz Carlos Bento Braz J Cardiovasc Surg Original Article INTRODUCTION: Active infective endocarditis is associated with high morbidity and mortality. Surgery is indicated in high-risk conditions, and the main determinants of mortality in surgical treatment should be evaluated. OBJECTIVE: To identify mortality predictors in the surgical treatment of active infective endocarditis in a long-term follow-up. METHODS: This prospective observational study involved 88 consecutive patients diagnosed with active infective endocarditis, who underwent surgery between January 2005 and December 2015. Fifty-eight (65.9%) patients were male, the mean age was 50.87±16.15 years. A total of 31 (35.2%) patients had a history of rheumatic fever; 48 (54.5%) had had heart surgery with prosthetic valve implantation; 45 (93.8%) had biological prosthetic valve endocarditis and 3 (6.3%) mechanical prosthetic valve; 40 (45.5%) patients had the disease in their native valve. The mean EuroSCORE II was 8.9±6.5%, and the main surgical indication was refractory heart failure in 38 (43.2%) patients. A total of 68 bioprosthesis (36 aortic, 32 mitral) and 29 mechanical prostheses (12 aortic, 17 mitral) were implanted and three mitral valve plasties performed. A total of 25 (28.4%) patients underwent double or triple valve procedures. Aortic annulus reconstruction by abscess was performed in 18 (20.5%) and six (6.81%) patients had combined procedure. The mean surgery time was 359±97.6 minutes. RESULTS: The overall survival in up to a 10-year follow-up period was 79.5%. In the univariate analysis, the main mortality predictors were positive blood cultures (P=0.003), presence of typical microorganisms (P=0.008), most frequently Streptococcus viridans (12 cases; 25%); C-reactive protein (hazard ratio [HR] 1.034, 95% confidence interval [CI] 1.000 to 1.070, P=0.04); creatinine clearance (HR 0.977, 95% CI 0.962 to 0.993, P=0.005); length of surgery: every five minutes multiplies the chance of death 1.005-fold (HR 1.005, 95% CI 1.001 to 1.009, P=0.0307); age (HR 1.060, 95% CI 1.026 to 1.096, P=0.001); and EuroSCORE II (HR 1.089, 95% CI 1.030 to 1.151, P=0.003). CONCLUSION: A positive blood culture with typical microorganism, C-reactive protein, age, EuroSCORE II, total surgical time and the presence of postoperative complications were the major predictors of mortality and significantly impacted survival in up to a 10-year follow-up period. Sociedade Brasileira de Cirurgia Cardiovascular 2018 /pmc/articles/PMC5873776/ /pubmed/29617499 http://dx.doi.org/10.21470/1678-9741-2017-0132 Text en http://creativecommons.org/licenses/by/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Original Article de Oliveira, Jenny Lourdes Rivas dos Santos, Magaly Arrais Arnoni, Renato Tambellini Ramos, Auristela Togna, Dorival Della Ghorayeb, Samira Kaissar Kroll, Roberto Tadeu Magro de Souza, Luiz Carlos Bento Mortality Predictors in the Surgical Treatment of Active Infective Endocarditis |
title | Mortality Predictors in the Surgical Treatment of Active Infective
Endocarditis |
title_full | Mortality Predictors in the Surgical Treatment of Active Infective
Endocarditis |
title_fullStr | Mortality Predictors in the Surgical Treatment of Active Infective
Endocarditis |
title_full_unstemmed | Mortality Predictors in the Surgical Treatment of Active Infective
Endocarditis |
title_short | Mortality Predictors in the Surgical Treatment of Active Infective
Endocarditis |
title_sort | mortality predictors in the surgical treatment of active infective
endocarditis |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5873776/ https://www.ncbi.nlm.nih.gov/pubmed/29617499 http://dx.doi.org/10.21470/1678-9741-2017-0132 |
work_keys_str_mv | AT deoliveirajennylourdesrivas mortalitypredictorsinthesurgicaltreatmentofactiveinfectiveendocarditis AT dossantosmagalyarrais mortalitypredictorsinthesurgicaltreatmentofactiveinfectiveendocarditis AT arnonirenatotambellini mortalitypredictorsinthesurgicaltreatmentofactiveinfectiveendocarditis AT ramosauristela mortalitypredictorsinthesurgicaltreatmentofactiveinfectiveendocarditis AT tognadorivaldella mortalitypredictorsinthesurgicaltreatmentofactiveinfectiveendocarditis AT ghorayebsamirakaissar mortalitypredictorsinthesurgicaltreatmentofactiveinfectiveendocarditis AT krollrobertotadeumagro mortalitypredictorsinthesurgicaltreatmentofactiveinfectiveendocarditis AT desouzaluizcarlosbento mortalitypredictorsinthesurgicaltreatmentofactiveinfectiveendocarditis |